Pre-Exposure Prophylaxis or PrEP

Pre-exposure prophylaxis (PrEP) involves putting HIV negative people on antiretroviral drugs (ARV) with the aim of protecting them from HIV infection. This blog looks at some of the pros and cons of PrEP.

Wednesday, November 10, 2010

AVAC is Not an Advocacy Group, it's a Pharmaceutical Industry Front

There's a brief article about PrEP in Medical News Today that promises a rash of mentions in the near future. But the article refers to AVAC (AIDS Vaccine Advocacy Coalition) as a HIV prevention advocacy group.

AVAC is no such thing. It is a front group for the drug industry, especially those producing HIV related drugs. It advocates strategies that increase the use of and dependence on antiretroviral drugs, both for HIV positive people and HIV negative people. For AVAC, prevention means drugs, lots of them.

The article and comments by Mitchell Warren, director of AVAC, is from a longer article in the New York Times. The usual suspects are involved, Bill Gates and the Gates Foundation, the Ford Foundation, the International Aids Vaccine Initiative, UNAIDS, WHO, all big supporters of technical solutions and drug multinationals.

allvoices

No comments:

Post a Comment